OKE vs SER · P/E 15, rev $21.70B vs rev $56.0K
ONEOK Inc (OKE) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
OKE currently screens at market cap $53.92B and trailing P/E 15.3. SER currently screens at market cap $29.7M.
Not investment advice. Open the OKE and SER stock pages for the full models.
Not investment advice.